Biohaven Ltd.
BHVN
$30.40
-$0.57-1.84%
| Weiss Ratings | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.49 | |||
| Price History | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -16.55% | |||
| 30-Day Total Return | -25.05% | |||
| 60-Day Total Return | -30.10% | |||
| 90-Day Total Return | -42.37% | |||
| Year to Date Total Return | -18.46% | |||
| 1-Year Total Return | -47.70% | |||
| 2-Year Total Return | 113.78% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -50.22% | |||
| 52-Week Low % Change | 15.56% | |||
| Price | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $62.21 | |||
| 52-Week Low Price | $26.80 | |||
| 52-Week Low Price (Date) | May 29, 2024 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.16B | |||
| Enterprise Value | 2.71B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -9.39 | |||
| Earnings Per Share Growth | 65.63% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 7.40 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $30.40 | |||
| Enterprise Value/EBITDA (TTM) | -3.13 | |||
| Enterprise Value/EBIT | -3.10 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 101.05M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 203 404 0410 | |||
| Address | 215 Church Street New Haven, CT 06510 | |||
| Website | www.biohaven.com | |||
| Country | United States | |||
| Year Founded | 2022 | |||
| Profitability | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -96.85% | |||
| Return on Equity | -- | |||
| Income Statement | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -866.36M | |||
| EBIT (TTM) | -874.21M | |||
| Net Income (TTM) | -846.42M | |||
| Net Income Avl. to Common (TTM) | -846.42M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -29.07% | |||
| EPS Diluted (TTM) | -9.39 | |||
| EPS Diluted Growth (Q YOY) | -2.09% | |||
| Balance Sheet | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 485.99M | |||
| Cash Per Share (Q) | $4.81 | |||
| Total Current Assets (Q) | 538.47M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 423.44M | |||
| Current Ratio (Q) | 3.491 | |||
| Book Value Per Share (Q) | $4.18 | |||
| Total Assets (Q) | 615.11M | |||
| Total Current Liabilities (Q) | 154.23M | |||
| Total Debt (Q) | 36.58M | |||
| Total Liabilities (Q) | 191.67M | |||
| Total Common Equity (Q) | 423.44M | |||
| Cash Flow | BHVN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -244.97M | |||
| Cash from Financing (TTM) | 677.77M | |||
| Net Change in Cash (TTM) | -149.58M | |||
| Levered Free Cash Flow (TTM) | -364.09M | |||
| Cash from Operations (TTM) | -582.45M | |||
